Нолпаза контроль 20 мг, 14 таблеток ентеросолюбільний. ПЕЧІЯ

Indications

Short-term management of symptoms of gastro-oesophageal reflux disease (E. G.heartburn, regurgitation) in adults.

активна речовина: Пантопразол

Composition

Each Gastro-resistant tablet contains 20 mg of pantoprazole (as pantoprazole sodium sesquihydrate).

Excipient: each Gastro-resistant tablet contains 18 мг сорбіту.

For a full list of excipients, see section 6.1.

Dosage

дозування

рекомендована доза становить 20 мг пантопразолу (1 таблетка) щодня.

щоб позбутися від симптомів, необхідно використовувати медикаментозний продукт для інших 2-3 днів. Treatment should be discontinued when symptoms have completely disappeared. Treatment should not exceed 4 weeks without consulting a doctor.

Patients should be instructed to consult a physician if symptoms not improve within 2 weeks of uninterrupted treatment.

Special groups of patients

Ну, дозування adjustment is necessary in elderly patients or in patients with renal or hepatic impairment.

Children and youth

the use of nolpaza control is not recommended in children and adolescents under 18 years of age.

years of age due to the limited amount of data on safety and efficacy.

Application method

nolpaza control gastro-resistant tablets should not be chewed or crushed. Вони повинні були прийняти їжу, проковтнувши всю воду.

Contraindications

Hypersensitivity to the active substance or any of the excipients listed in section 6.1.

Co-administration with atazanavir (see section 4.5).

Contents: